human immunoglobin (pH4) for Intravenous Injection (China biologic products holdings)
人免疫球蛋白（pH4, 山东泰邦）
Report date: 2022/01/14 13:23:58
Base Information
Drug Namehuman immunoglobin (pH4) for Intravenous Injection (China biologic products holdings)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2001/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTaibang Biotech (Shandong) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShandong Taibang Biological Products Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A